
Second-place honor for short-talk Mohs AI tool during PhD retreat
Daan Geijs' short-talk on the development of a Mohs surgery AI tool was reviewed as second-best during the annual PhD retreat of RIHS. Read more →
The Computational Pathology Group develops, validates and deploys novel medical image analysis methods based on deep learning technology.
Daan Geijs' short-talk on the development of a Mohs surgery AI tool was reviewed as second-best during the annual PhD retreat of RIHS. Read more →
From February 1, 2022, Jeroen van der Laak was appointed full professor of computational Pathology at the Radboud UMC. Read more →
Wouter Bulten succesfully defended his PhD thesis titled 'Artificial intelligence as a digital fellow in pathology: human-machine synergy for improved prostate cancer diagnosis.' on the 28th of January. Read more →
After two years of hard work, the final results of PANDA Challenge on AI for prostate cancer grading are published! Read more →
The European Research Council awarded Geert Litjens with a grant for his project "AIS-CaP: Interpretable Artificial Intelligence across Scales for Next-Generation Cancer Prognostics". Read more →
The DKF awarded the grant to CPG’s Meyke Hermsen, Dominique van Midden, and Jeroen van der Laak for their proposal to use AI for improved histopathologic kidney biopsy assessment. Read more →
Francesco Ciompi and Chella van der Post have been awarded 400,000 euros for the execution of their project aimed to develop AI solutions for improving DGC diagnostics. Read more →
CPG launches new spin-off, Aiosyn, to accelerate the implementation of AI in Pathology Read more →
Aim of the presently proposed ‘proof of concept‘ study is to develop digital pattern recognition algorithms (more specifically: deep neural networks) for the extraction of morphological features from scanned H&E stained tissue sections from TNBC which are indicative for the risk of recurrence.
Development of AI-biomarkers to predict neoaduvant chemotherapy response in breast cancer.
Development of a deep learning system to unmix IHC stainings with multiple colors
The goal of AQUILA is to investigate the prognostic value of Tumor Infiltrating Lymphocytes (TILs) in breast and colon cancer.
Read more →The aim of this project is to use deep learning for histological assessment of the stroma for improved risk stratification of ductal carcinoma in situ (DCIS) patients.
Read more →In this project, we will combine deep learning and digitized whole-slide imaging of prostate cancer for reproducible extraction of quantitative biomarkers.
Read more →The aim of ExaMode is to collect training data with limited human interaction for the processing of exascale volumes of healthcare data.
Read more →We aim to combine advanced CT and FDG-PET image analysis with computational pathology to predict the most optimal treatment for each individual patient.
Read more →The aim of PROACTING is to predict neoadjuvant chemotherapy treatment response from a single pre-operative core-needle biopsy of breast cancer tissue.
Read more →The investigation of the role of immune cell subsets in interstitial fibrosis and tubular atrophy in renal allografts, using multiplex immunohistochemistry and Deep Learning.
Read more →Developing an algorithmn that can automatically detect and segment tumor-infiltrating lymphocytes in breast cancer.
Read more →In this project, we will develop and validate digital image analysis algorithms for quantification of tumor budding from scanned whole slide images.
Read more →